174 related articles for article (PubMed ID: 32903892)
1. Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver.
Golmohammadi S; Tavasoli M; Asadi N
Clin Exp Gastroenterol; 2020; 13():299-304. PubMed ID: 32903892
[TBL] [Abstract][Full Text] [Related]
2. Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study.
Akahane T; Akahane M; Namisaki T; Kaji K; Moriya K; Kawaratani H; Takaya H; Sawada Y; Shimozato N; Fujinaga Y; Furukawa M; Kitagawa K; Ozutsumi T; Tsuji Y; Kaya D; Mitoro A; Yoshiji H
J Clin Med; 2020 May; 9(6):. PubMed ID: 32481684
[TBL] [Abstract][Full Text] [Related]
3. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses.
Ma Z; Zhang J; Kang X; Xu C; Sun C; Tao L; Zheng D; Han Y; Li Q; Guo X; Yang X
Atherosclerosis; 2020 Oct; 311():44-51. PubMed ID: 32937242
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients.
Oral A; Sahin T; Turker F; Kocak E
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31533345
[No Abstract] [Full Text] [Related]
8. Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease.
Luo K; Bian J; Wang Q; Wang J; Chen F; Li H; Jin D
Turk J Gastroenterol; 2019 Jul; 30(7):611-615. PubMed ID: 31290748
[TBL] [Abstract][Full Text] [Related]
9. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease.
Zhou M; Yang N; Xing X; Chang D; Li J; Deng J; Chen Y; Hu C; Zhang R; Lu X; Zhao Y; He Y
BMC Gastroenterol; 2021 Jan; 21(1):43. PubMed ID: 33509116
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
Behairy MA; Sherief AF; Hussein HA
Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center.
Sandra S; Lesmana CRA; Purnamasari D; Kurniawan J; Gani RA
Diabetes Metab Syndr; 2019; 13(1):424-428. PubMed ID: 30641737
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
13. Study on the independent effect of thyroid hormone based on uric acid level on NAFLD.
Chao G; Chen L
J Health Popul Nutr; 2021 May; 40(1):21. PubMed ID: 33941292
[TBL] [Abstract][Full Text] [Related]
14. Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.
Lin H; Li Q; Liu X; Ma H; Xia M; Wang D; Li X; Wu J; Zhao N; Pan B; Gao X
PLoS One; 2015; 10(10):e0140379. PubMed ID: 26473493
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
[TBL] [Abstract][Full Text] [Related]
16. Preliminary Study on Risk Factors for Morbidity of Nonalcoholic Fatty Liver Disease in High-Income Male Population.
Han L; Zhang Y; Yue C; Huang Y; Wu Y; Chen J
J Healthc Eng; 2022; 2022():9331284. PubMed ID: 35251583
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It.
Yen PC; Chou YT; Li CH; Sun ZJ; Wu CH; Chang YF; Lu FH; Yang YC; Chang CJ; Wu JS
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268536
[TBL] [Abstract][Full Text] [Related]
18. The Negative Association Between NAFLD Severity and CKD in a Non-Diabetic Gouty Population.
Huang Y; Zhou Y; Wang Y; Chi J; Lv W; Wang Y; Chen Y
Horm Metab Res; 2022 May; 54(5):325-334. PubMed ID: 35378561
[TBL] [Abstract][Full Text] [Related]
19. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.
Önnerhag K; Dreja K; Nilsson PM; Lindgren S
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):542-550. PubMed ID: 30827925
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
